Article Information
History
- June 14, 2022.
Article Versions
- Version 1 (March 12, 2022 - 23:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sergio Kaiser1,†,
- Luqing Zhang2,†,
- Brit Mollenhauer3,
- Jaison Jacob2,¶,
- Simonne Longerich5,
- Jorge Del-Aguila5,
- Jacob Marcus5,
- Neha Raghavan5,
- David Stone6,
- Olumide Fagboyegun6,
- Douglas Galasko7,
- Mohammed Dakna3,
- Bilada Bilican4,$,
- Mary Dovlatyan4,
- Anna Kostikova1,
- Jingyao Li4,
- Brant Peterson4,#,
- Michael Rotte1,
- Vinicius Sanz4,
- Tatiana Foroud8,
- Samantha J. Hutten9,
- Mark Frasier9,
- Hirotaka Iwaki10,
- Andrew Singleton10,
- Ken Marek11,
- Karen Crawford12,
- Fiona Elwood4,§,
- Mirko Messa4,* and
- Pablo Serrano-Fernandez1,*
- 1Translational Medicine Department. Novartis Institutes for Biomedical Research. Basel, Switzerland
- 2Cardiovascular and Metabolism Department. Novartis Institutes for Biomedical Research. Cambridge, USA
- 3Department of Neurology, University Medical Center Göttingen. Göttingen, Germany
- 4Neuroscience Department. Novartis Institutes for Biomedical Research. Cambridge USA
- 5Genome and Biomarker Sciences. Merck Exploratory Science Center. Cambridge, USA
- 6Department of Genetics, Cerevel Therapeutics. Cambridge, USA
- 7Department of Neurosciences, University of Southern California, San Diego. La Jolla, USA
- 8Department of Medical and Molecular Genetics, Indiana University School of Medicine. Indianapolis, USA
- 9Michael J. Fox Foundation for Parkinson’s Research. New York, USA
- 10Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health. Bethesda, USA
- 11Institute for Neurodegenerative Disorders. New Haven, USA
- 12Laboratory of Neuroimaging, University of Southern California. Los Angeles, USA
- ↵*Correspondence to: Dr. Mirko Messa, Full address: Neuroscience Department. Novartis Institutes for Biomedical Research. 250 Massachusetts Avenue, Cambridge (MA) USA. ZIP/Postal code, 02139, E-mail: mirko.messa{at}novartis.com Or Dr. Pablo Serrano-Fernandez, Full address: Translational Medicine Department. Novartis Institutes for Biomedical Research. Fabrikstrasse 10, Novartis Campus, CH-4056 Basel, Switzerland. E-mail: pablo.serrano{at}novartis.com
↵† These authors contributed equally to this work.
Posted June 14, 2022.
